ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,622Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 309

$532K Total Retail Price of All Prescriptions

Rank: 19 out of 309

281 Patients Receiving at Least One Drug in Part D
39%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 281 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

49% of this provider’s 281 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 3,352 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $88 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 888 282 S3 1 1
LISINOPRIL 465 218 2 2
GABAPENTIN 288 60 3 8
OMEPRAZOLE 270 123 4 4
CARVEDILOL 217 87 5 17
LEVOTHYROXINE SODIUM 198 85 6 3
RANITIDINE HCL 194 81 7 37
METFORMIN HCL 184 69 8 9
PROMETHAZINE HCL 182 40 R 9 69
CITALOPRAM HBR 161 62 10 16
CARISOPRODOL 144 0 R 11 142
AMLODIPINE BESYLATE 138 53 12 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 137 60 13 28
FUROSEMIDE 137 75 13 7
HYDROCHLOROTHIAZIDE 129 51 15 10
TRAMADOL HCL 121 17 16 15
SIMVASTATIN 120 51 17 5
TIZANIDINE HCL 120 0 17 42
PROAIR HFA 119 34 19 29
ATORVASTATIN CALCIUM 114 43 20 13
PRAVASTATIN SODIUM 107 71 21 12
ISOSORBIDE MONONITRATE ER 106 40 22 40
ZOLPIDEM TARTRATE 103 27 23 18
CRESTOR 96 14 24 26
SINGULAIR 94 50 25 116
MELOXICAM 86 17 26 27
SERTRALINE HCL 85 26 27 19
CYCLOBENZAPRINE HCL 84 14 R 28 31
DICLOFENAC SODIUM 83 26 29 117
POTASSIUM CHLORIDE 82 39 30 21
NEXIUM 77 35 31 33
METOPROLOL TARTRATE 73 49 32 11
CLOPIDOGREL 72 17 33 34
IBUPROFEN 69 11 34 114
ROPINIROLE HCL 68 29 35 81
OXYCODONE HCL-ACETAMINOPHEN 68 16 S2 35 35
LYRICA 68 0 35 59
MONTELUKAST SODIUM 62 27 38 169
QUETIAPINE FUMARATE 61 0 39 73
CLONIDINE HCL 61 19 39 96
FLUTICASONE PROPIONATE 59 13 41 102
SEROQUEL XR 53 0 42 80
POLYETHYLENE GLYCOL 3350 52 33 43 98
WARFARIN SODIUM 51 14 44 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.